The escalating cost of drug development and unacceptably high Phase III failure rates are well-known challenges in our industry where the root causes are numerous and diverse. As we search for solutions to these challenges, the ability to design better protocols and to select the right patients, sites and countries have emerged as two key success factors. This webinar evaluates the challenges of current practices and unique and innovative approaches that leverage data to enable real-time scenario planning during the initial phases of study design.

Key Highlights:

• Reasons why many Phase III trials fail and what companies are doing to mitigate the risk of failure.
• Approaches to take to design better protocols and improve feasibility to avoid amendments (where possible) and mitigate failure risk as much as possible.
• Sources of investigator databases and the benefits of mastering data aggregation.
• Future possibilities for extending analytics to provide a mission control center for clinical trials.